FDA.reportPublic FDA data

Application 202602

Type
ANDA
Sponsor
ZYDUS PHARMS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001EXEMESTANEEXEMESTANETABLET;ORAL25MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
68382-383ExemestaneExemestaneZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-383ExemestaneExemestaneZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-383ExemestaneExemestaneZydus Pharmaceuticals USA Inc.ANDACurrent
68382-383ExemestaneExemestaneZydus Pharmaceuticals (USA) Inc.ANDACurrent
70771-1374ExemestaneExemestaneCadila Healthcare LimitedANDACurrent
70771-1374ExemestaneExemestaneCadila Healthcare LimitedANDACurrent
70771-1374ExemestaneExemestaneZydus Lifesciences LimitedANDACurrent
70771-1374ExemestaneExemestaneCadila Healthcare LimitedANDACurrent